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INTRODUCTION 
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INTRODUCTION 
 Abnormal  Uterine  Bleeding  (AUB)  is  a  very  common  
presenting  illness  among  women  attending  Gynaecology  OPD
1
,  
diagnosis  of  which  is  often  difficult  as  the  cause  may  be  widely  
variable  from  simple  DUB  to  endometrial  carcinoma.  It  accounts  
for  about  15%  of  office  visits  and  almost  25%  of  gynecological  
surgeries
2
.  Hysteroscopy  with  directed  biopsy  has  now   become  the  
reference  standard  investigation  for  AUB.  This  is  because  of  its  
accuracy  in  diagnosing  the  endometrial  abnormalities  and  the  
feasibility  of  treatment  in  the  same  sitting.  However  it  is  not  used  
as  a  primary  diagnostic  procedure  in  patients  with  AUB
3
.  This is  
because  of  its  invasive  nature  and  high  cost. 
 Transvaginal  sonography (TVS)  has  an  important  role  in  the  
initial  evaluation  of  AUB  as  it  is  highly  applicable  and  non  
invasive
4
.  However  its  ability  for  screening  the  lesions  in  the  
endometrial  cavity  and  focal  endometrial  lesions  is  limited.  This can  
be  overcome  by  Saline  Infusion  Sonography (SIS).  It  can  be  
performed  easily  and  rapidly  and  is  well  tolerated  by  the  patients.  
It  can  accurately  differentiate  focal  endometrial  lesions  and  provides  
information  about  the  localization  and  the  extent  of  subendometrial  
lesions  affecting  the  uterine  cavity
5
.   
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The  infusion  of  saline  serves  as  a  contrast  medium  
and  distends  the  endometrial  canal.  This  allows  exquisite  display  
of  the  inner  lining  of  endometrium  during  real  time  imaging.  
This  procedure  is  known  by  many  names  such  as  
sonohysterography,  ultrasonohysterography  and  saline  infusion  
sonography.
6 
Today  saline  infusion  sonography  has  evolved  as  a  useful,  
safe  and  minimally  invasive  examination  for  women  who  have  
abnormal  uterine  bleeding,  infertility  and  congenital  uterine  
anomalies
6
. 
 
  
 
 
 
 
 
 
 
 
AIM AND OBJECTIVES 
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AIMS AND OBJECTIVES 
To evaluate the diagnostic effectiveness of transvaginal 
sonography and  saline infusion  sonography  in women presenting with  
abnormal  utetrine  bleeding  and  comparing  them with  histopathology 
as the gold  standard  diagnostic  method.  
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REVIEW OF LITERATURE 
 S.Alborzi  et  al
7
 made  a  study  on  comparison  of   the  accuracy  
of   Transvaginal  sonography  with  Saline  Infusion  Sonohysterography  
for  the  screening  of  the  causes  of  AUB.   The  conclusion  is   that  
SIS  is  better  than  TVS. 
Statistical  value SIS TVS 
Sensitivity 94.1% 72% 
Specificity 95% 92% 
Positive predictive value 96% 94% 
Negative predictive value 90% 64% 
 
 Reddi  Rani  P,  Lakshmikantha  G
8
  from  Jawaharlal  Institute  of  
Postgraduate  Medical  Education  (  JIPMER  )  have  done  a  study  on  
Transvaginal  Sonography  and  Saline  Infusion  Sonohysterography  in  
the  evaluation  of  AUB.  The  conclusion  is   that  SIS  has  better  
sensitivity  and  specificity  than  TVS.  This is tabulated below. 
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Statistical  value SIS TVS 
Sensitivity 82% 65.5% 
Specificity 95% 88% 
Positive  predivtive  value 81% 68% 
Negative  predictive value 93% 90% 
 
  Mohammad  Ali  Karimzadeh  M.D et al
9
  did  a  study  on  
diagnostic  value  of  saline  contrast  sonohysterography  comparing  
with  hysteroscopy  for  detecting  endometrial  abnormalities  in  women  
with  AUB.  The  results  are  tabulated. 
Lesion Sensitivity Specificity 
Polyp 73.3% 96% 
Hyperplasia 71.4% 82.3% 
Submucous  myoma 90.9% 90.7% 
  
  Sensitivity  and  specificity  for  detecting  submucous  myoma  is  
higher  for  sonohysterography  than  hysteroscopy.  However  it  is  not  
so  in  case  of  endometrial  polyp  and  endometrial  hyperplasia. 
6 
 
Suna  Soguktas  et  al
10
  did  a  study  to  compare  the  diagnostic  
efficacy  of  TVS,  SIS  and  diagnostic  hysteroscopy(HS).  They  took  
histopathology  as  gold  standard.  The  most  common  abnormality  
detected  was  polyp.  Comparing  the  three  procedures  with  each  
other  separately, the   diagnostic  accuracy  was  best  with  HS.  HS  and  
SIS  were  superior  to  TVS  with  (p1  =  0.000,  p2  =  0.000).  They  have  
commented   that  TVS  should  be  a first  line  investigative  modality   
in  the  evaluation  of   AUB,  though   its  role  in  the  differential  
diagnosis  of  intracavitary  abnormalities   is  limited.  SIS  and  HS  are  
alternative  diagnostic  procedures.  In   the  detection  of  intracavitary  
abnormal  pathologies   they  are  more  effective
11 
In  this  study  they  have  compared  Area  Under  the  Curve  
(AUC)  values  which  is  a  better  method  of  statistical  analyses  of  
the  diagnostic  performances.  AUC  is  a  measure  of  the  overall  
efficacy  of  a  diagnostic  test.  It is interpreted as the average value of 
sensitivity for all possible values of  specificity
12,13
.  The  conclusion  is  
that  HS  provides  the  most  accurate  diagnosis  and  there  is  a  
provision  for  treatment  in  the  same  session. 
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Kelekci  et  al
14  
did  a  study  regarding  the  detection  of    
endometrial  polyp  with  saline  infusion  sonogram.  They  got  a  
sensitivity  of  70%,  whereas  the  specificity,  positive  predictive  value  
and  negative  predictive  value  were  100  %,  100  %  and  90.9  %  
retrospectively.  However  in  the  detection  of  submucous  myoma  all  
of  these  parameters  were  100  %.     
Yildizhan  B  et  al
15  
has  said  that  Saline  infusion  sono 
hysterography  is  an  acceptable  method  of  identifying  endometrial  
lesions.  It  is a  less  invasive  alternative  to  hysteroscopy.   
Muhammad  Aslam,  et  al
16
  conducted  a  study  comparing  TVS  
and  SIS  and  correlated  them  with  hysteroscopy  and  histopathology.   
Procedure SIS TVS 
Sensitivity(%) 92.9 71.4 
Specificity(%) 89.7 67.7 
   
They  say  that  SIS  is  a  better  investigation  than  TVS  for  the  
evaluation  of  endometrial  intracavitary  lesions.  It  can  be  decided  
whether  hysteroscopy  is  needed  or  not  based  on  the  findings  of  
SIS.   
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  Salvatore  Dessole  M.D.  et  al
17
  have  performed  a  study  to  
evaluate  the  risks  and  usefulness  of  sonohysterography  in  patients  
with  endometrial  carcinoma.  Depth of myometrial  invasion  was  
evaluated  using  SIS.  After  hysterectomy  the  specimen  was  
sectioned,  the  depth  of  gross  myometrial  invasion  was  visually  
estimated  by  surgical  oncologist. Total number of cases taken was 32. 
 
Procedure SIS Gross  examination 
No.  detected  correctly 27 25 
%  detected  correctly 84.37 78.12 
 
They concluded that SIS is a simple and safe procedure.  However  
in  high  risk  patients  it  should  be  carried  out  with  caution. 
  Chiou  Li  Ong,  MD,  MBBS,  FRCR
18  
did  a  study  on  Saline  
infusion  sonohysterography  and  termed  it  as  a  useful  adjunct  to  
TVS  for  the  evaluation  of  endometrial  cavity.  SIS  had  a  sensitivity  
of  98 %  to  100 %  whereas  that  for  TVS  was  75 %  to  92 %. 
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Prachi  Renjhen  MD,  S.Kanagasabai  FRCOG
19
  studied  the  role  
of  sonohysterography  in  the  evaluation  of AUB. 
Procedure Sensitivity Specificity 
TVS 83  % 70.6  % 
SIS 95  % 88  % 
Hysteroscopy 100  % 100  % 
 
Thus  it  is  evident  that  saline  sonohysterography  improves  the  
diagnostic  accuracy.  
Frank  K  Willem  Jansen  MD,  PhD  et  al
20
,  made  a  study  
of  Diagnostic  hysteroscopy  and  saline infusion   sonography   in  the  
prediction  of  intra  uterine  polyps  and  myomas.  The  positive  
predictive  values  of  SIS  and  diagnostic  hysteroscopy  in  the  
evaluation  of  intrauterine  polyps and  fibroids  did  not  significantly  
differ.  However,  p = 0.3  is  the  significant  difference  for  the   
positive   predictive  value  of  SIS  in  pre  menopausal  women  
comparing  the  positive  predictive  value  of  SIS  for  fibroids  (0.95),  
and  for  polyps  (0.81).  Their  study  concluded  that  diagnostic  
hysteroscopy  and  SIS  are  equivalent  diagnostic  tools  for  the  
detection   of  intrauterine  myomas  and   polyps. 
10 
 
ABNORMAL UTERINE BLEEDING 
 ACOG  defines  AUB
21
  as  bleeding  from  the  uterine  corpus  
that  is  abnormal  in  regularity,  volume,  frequency  or  duration  and  
occurs  in  the  absence  of  pregnancy.  It   may be acute or chronic. 
Incidence  of  Abnormal  Uterine  Bleedding
23 
 Reproductive  age  group  –  10    to    30  % 
 Perimenopausal  age  group –  50  %   
ETIOLOGY OF ABNORMAL UTERINE BLEEDING 
Etiology of AUB varies according to the age group of the patient. 
I. REPRODUCTIVE  AGE  GROUP 
a) Pregnancy  related  complications 
 Ectopic  pregnancy 
 Abortion 
 Gestational  trophoblastic  disease 
 Placenta  praevia 
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b) Anovulation 
 Polycystic  ovarian  disease 
 Thyroid  disease 
c) Uterine  pathologies 
 Fibroids 
 Endometrial  polyps 
 Endometriosis 
 Pelvic  Inflammatory  Disease 
d) Contraceptives 
 Intrauterine  contraceptive  device 
 Combined oral contraceptives 
e) Hormone  producing  tumours  of  ovary 
 granulosa  cell  tumours 
 theca  cell  tumour 
f) Malignant  condition 
 Endometrial  Carcinoma 
 Carcinoma  cervix 
12 
 
 Carcinoma  vulva 
 Carcinoma  vagina 
g) Systemic  diseases 
 Hepatic  diseases 
 Renal  diseases 
 Adrenal  dysfunction  /  tumour 
 Coagulopathy 
 Thrombocytopenia 
II. PERIMOPAUSAL  AGE  GROUP 
a) Anovulation  15% 
b) Uterine  lesions 
 Fibroids  18  to  20% 
 Polyps 
 Adenomyosis 
 Endometrial  hyperplasia  1-7% 
 Endometrial  Carcinoma  3  to  5  % 
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c) Hormones  producing  tumour  of  ovaries 
 Granulosa  cell  tumour 
 Sertoli  leydig cell  tumour 
 Gynandroblastoma  of  feminising  type 
III. POST  MENOPAUSAL  AGE  GROUP 
a) Benign  conditions 
 Senile  vaginitis 
 Atrophic  endometritis 
 Endometrial  polyps 
 Cervical  polyps 
 Vulval  dystrophies 
 Trauma 
 Hormone  replacement  therapy 
b) Feminising  &  hormone  producing  tumours  of  ovary 
 Granulosa  cell  tumor 
 Theca  cell  tumour 
 Gynandroblastoma  of  feminising  type 
14 
 
NEW FIGO CLASSIFICATION OF ABNORMAL UTERINE 
BLEEDING (AUB) 
Terminologies  used  to  describe  abnormal  uterine  bleeding  were: 
Menorrhagia   
Menorrhagia is defined as regular cycle with prolonged or heavy 
bleeding.  The  determining  value  is  a  blood  loss  of  more than  80  
ml. 
Polymenorrhoea   
It  is  defined  as  frequent  cycles  where  the  cycle  length  is  
decreased  to  an  arbitrary  limit  of  <  21days    but  normal  bleeding . 
Polymenorrhagia   
Cycles  are  not  only  shortened  to  less  than  21  days,  but  
bleeding  is  prolonged  and  / or  excessive. 
Metrorrhagia   
Metrorrhagia  is  inter  menstrual  acyclical    bleeding  of  varying  
amounts  but  not  excessive. 
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Menometrorrhagia 
When  the  bleeding  is  so  irregular  and  excessive  that  
the  menses  cannot  be  identified  at  all  the  term  applied  is  
menometrorrhagia. 
These  confusing  terminologies  are  discarded by FIGO  in  2009  
and  replaced with  the  new simple  descriptive terminologies. The  new  
PALM COEIN system  was  published by FIGO in 2009  and  is  
accepted by ACOG in 2012. 
Accepted Terminologies by FIGO and ACOG: 
Following are the terminologies accepted by FIGO and ACOG.         
AUB   - Abnormal  uterine  bleeding   
HMB  -  Heavy  menstrual  bleeding   
HPMB  - Heavy  and  prolonged  menstrual  bleeding   
IMB   -  Intermenstrual  bleeding     
PMB   - Postmenopausal  bleeding  . 
  
16 
 
Acute AUB   
Acute  AUB
21
  is  defined  as  an  episode  of  bleeding  in  a  
woman  of  reproductive  age,  who  is  not  pregnant,  of  sufficient  
quantity  to  require  immediate  intervention  to  prevent  further  blood  
loss.   
Chronic  AUB   
Chronic  AUB
21
  is  defined  as  bleeding  from  the  uterine  corpus  
that  is  abnormal  in  duration,  volume,  and/or  frequency  and  has  
been  present  for  the  majority  of  the  last  6  months. 
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New  FIGO  Classification  of    Abnormal  Uterine  Bleeding
22
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PALM – COEIN  CLASSIFICATION22 
According  to  this  new  classification  there  are  9  basic  
categories  arranged    in  the  order  of    PALM  –  COEIN.   
PALM  denotes  the  organic  or  the  structural  causes  of  AUB,  
whereas  COEIN  signifies  the    functional  causes  of  AUB.   
PALM  –  COEIN  is  abbreviated  as 
P   –  Polyp 
A   –  Adenomyosis 
L   –  Leiomyoma 
M    –  Malignancy  or  Hyperplasia 
C    –  Coagulopathy 
O   – Ovulation 
E  – Endometrial 
I    –  Iatrogenic 
N    –  Not  otherwise  classified 
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Polyps  (  AUB  -  P  )  : 
Polyp is  categorized  and  defined  by  ultrasonography,  saline  
infusion  sonography,  hysteroscopy  with  or  without  histopathology.  
Polyps  are  common  tumours  in  the  uterus.  They  are  usually  
benign.  Polyps  are  small  pink or  red  tumours  projecting  from  the  
surface  of  the  endometrium.  A  polyp  is  composed  of  endometrial  
stroma  and  glands  covered  by  a  single  layer  of  columnar  
epithelium.  Endometrial  polyps  are  commonest  in  the  body  of  the  
uterus.  They  are  mostly  multiple,  sometimes  as  a  part  of  a  
hyperplastic  endometrium,  but  after  the  menopause  they  are  single  
or  few  in  number
25
 .   
Aadenomyosis   (AUB  –   A): 
Adenomyosis  is  defined  as  the  presence  of  endometrial  tissue  
in  myometrium  atleast  1  high  power  field  (  2.5  cm  )  from  the  
basal  layer  of  endometrium.  Endometrial  glands  and  stroma  must  
be  present.  It  may  be  diffuse  adenomyosis  or  localized  
adenomyosis  (adenomyoma).  It  can  be  diagnosed  by  ultrasound  
examination and   Magnetic  resonance  imaging.      However  MRI  is  
expensive  and  hence  may  not  be  available  in  many  centres.  In  
such  cases  ultrasound  alone  can  be  used  for  the  diagnosis.  Upon  
ultrasound  examination,  adenomyosis  may  present  with  heterogenous  
20 
 
myometrial  echotexture,  ill-defined  anechoic  areas  of  thickened  
myometrium  consisting  of  blood  filled,  irregular  cyctic  spaces,  or  
as  an  area  of  hyperechoeic  myometrium  with  several  cysts.  This  
category  of  the  PALM-COEIN  may  be  further  subdivided  based  on  
the  depth  of  endometrial  myometrial  invasion
26
.   
Leiomyoma  (  AUB  –  L  )    : 
According  to  the  number,  size  and  different  locations,  this  
group  is  further  subclassified  into  primary,  secondary  and  tertiary  
groups.  The primary classification  is  based  on  the  ultrasound  findings  
i.e.  either  presence  or  absence  of  leiomyoma.  Myomas  that  involve  
the  uterine  cavity  are  distinguished  in  secondary  classification.  It  is  
essential  because  only  these  myomas  cause  AUB.  Submucosal  
growths  come  under  the  tertiary  classification.   
Abnormal  uterine  bleeding  may  be  associated  with  submucous,  
intramural  and  subserous  fibroids,  but  there  is  a  distinct  clinical  
impression  that  bleeding  is  more  common  and  severe  in  the  
presence  of  submucous  myomas.  The  submucous  myoma  bleeds  
freely  at  menstruation  and  may  also  bleed  in  between  periods  as  a  
result  of  necrosis,  passive  congestion,  and  ulceration  of  the  
endometrial  surface  over    the  tumour  and  ulceration  of  the  contra  
lateral  surface.  If  the  submucous  myoma  is  pedunculated,  there  is  
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usually  a  thin  blood  tinged  discharge  in  addition  to  the  
menorrhagia.  An  intramural  tumour  that  is  just  beginning  to  
encroach  on  the  uterine  cavity  can  also    be  responsible  for  
menorrhagia.  There  are  several  mechanisms   by  which  leiomyoma  
can    cause  abnormal  bleeding   although  a single  specific  mechanism  
may  not  be  apparent  in  a  particular  patient.  The  surface  area  
of  endometrial  cavity  in  a  normal  uterus  is  15cm2.  The  
surface  area  of  the  endometrial  cavity  in  presence  of  
leiomyomata  may  exceed  200cm2.  There  may  be  a  correlation  
between  the  severity  of  bleeding  and  the  area  of  endometrial  
surface.  The  endometirum  may  demonstrate  local  hyperestrogenism  
in  areas  immediately  adjacent  to  submucous  tumours  in  the  
form  of  endometrial  hyperplasia  and  endometrial  polyps.  The  
presence  of  leiomyoma  may  interfere  with  myometrial  contractility  
as  well  as  contractility  of  the  spiral  arterioles  in  the  basalis  
portion  of  the  endometirum
27
. 
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Malignancy  and  premalignant  lesions  (  AUB  )  : 
Malignancy  is  rare  in  the  reproductive  age  group.  It  can  
occur  in  women  with  PCOS  and  chronic  anovulation.  Endometrial  
thickness  can  be  measured  by  transvaginal  sonogram  and  saline  
infusion  sonogram.  However  the  definitive  diagnosis  of  endometrial  
carcinoma  and  endometrial  hyperplasia  can  be  done  only  by  
histopathological  examination
26
. 
Coagulopathy  (  AUB  –  C  ): 
Systemic  disorders  of  hemostasis  that  cause  AUB  come  
under  this  group.  This  constitute  for  about  13-20%  of  women  with  
AUB.  The  most  common  coagulopathy  is  von  Willebrand‟s  
disease
26
.  90  %  of  them  can  be  identified  by  a  structured  history
24
. 
Ovulatory  disorders  (  AUB  –  O  ): 
Anovulatory  cycles  contribute  about  80%  of  people  with  
AUB  with  irregular  menstrual  cycles  and  some  with  heavy 
bleeding.  20%  are  ovulatory  but  may  be  an  outcome  of  Luteal –
Out – of  –phase  (LOOP)  events  which  are  due  to  deficiency  of  
progesterone
24
.    Endocrinopathies  causing  AUB  also  come  under  
this  group.   
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Endometrial  causes  (  AUB  –  E    )  : 
Abnormal  secretion  of  prostaglandins    leads  to  dysregulation  
of  the  mechanisms  of  local  endometrial  hemostasis
24
.  Also  in  our  
country  it  is  not  uncommon  to  find  tubercular  endometritis  and  
other  infections  causing  AUB. 
Iatrogenic  (  AUB  –  I  )  : 
These  include  the  steroidal  hormones, anticoagulants,  
phenothiazines  and  tricyclic  antidepressants    which  affect  dopamine  
metabolism.  Contraceptive  pills,  IUCD  come  under  this  group. 
Not  classified  (  AUB  –  N  ): 
Rare  causes  like  arteriovenous  malformations,  varicose  veins  
of  the  uterine  vessels,  myohyperplasia  come  under  this  group.  In  
others  no  specific  cause  could  be  found  out  with  the  available  
investigations.   
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EVALUATION OF A PATIENT WITH AUB 
In some women with AUB there may be no cause identifiable. In 
some others there may be multiple factors identified to be responsible for 
AUB28.    Evaluation   should  begin  with  a  proper  history  taking,  
thorough physical  examination  and    appropriate    investigations. 
History  should  begin  with  age of the  patient  since  the cause    
of AUB  varies  according  to  the  age of  the  patient.    Menstrual    
history  should  be properly  elicited.  Regularity,  frequency,  duration    
of  bleeding  and  volume  of  blood  loss  should  be  correctly    noted.    
History of  postcoital  bleeding  should    be    enquired    about.    History    
of    dysmenorrhoea  and    dyspareunia    should    also    be  asked    for.  
History  of   recent   abortion,    delivery and ectopic pregnancy    should 
be noted.    Use    of    oral    contraceptives,    intrauterine    contraceptive 
devices, hormone therapy and drugs taken should also be taken  into    
account.   
Symptoms   related   to  thyroid  disorder   or   any   symptom  of    
bleeding  disorder    should    be    considered    while    performing    the    
investigations.     
Examination should  begin from a general  physical    examination,  
thyroid  and  breast  examination.  BMI  should  be  calculated.   Proper  
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speculum  examination  and  a  thorough   pelvic  examination  should   
be  carried  out.  Fornices  should  be  examined  for  adnexal  mass,  
tenderness  and  induration. 
Investigations  performed  are 
Laboratory  tests:   
1. Hb,  TC/DC  –  to  know  the  degree  of  anaemia,  
2. BT,  CT,  Platelet  count  –  to  exclude  coagulation disorders and  
leukaemia,   
3. T  3  ,  T  4  &  TSH    -    to  know  thyroid    disorders 
4. Fasting    blood    sugar    -    to    know    the    state    of    diabetes 
Imaging  techniques: 
Transabdominal    sonography, 
Transvaginal    sonography, 
Saline    infusion  sonography 
Direct  visualization  of  endometrial  cavity  by  hysteroscope   
 
 
 
26 
 
Endometrial    sampling: 
Various  sampling  methods  are  available  namely  Novak‟s  
curette,  Vibra  aspirator,  Karman  canula  with  syringe,  pipelle  curette,  
dilatation  and  curettage  and  hysteroscopy  directed  biopsy. 
Magnetic  resonance  imaging  –  only  in  rare    situations  to  
confirm  Adenomyosis,etc, 
Angiography  and    Venography  –  only  in  case  where  uterine  
A-V  malformations  are  suspected. 
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ULTRASONOGRAPHY 
Though  so  many  noninvasive  modalities  have  been  developed    
to  image  the  female  pelvis,  ultrasonography  still  continues  to  be  the  
most  accepted  modality  in  imaging  uterus  and  adnexa. 
Physics  Of  Ultrasound 
The  basic  principle  of  the  high  frequencies  and  directional  
beams  required  in  medical  ultrasound    is  the  reverse  Piezo  electric  
effect.  The  Piezo  electric  effect  was  first  discovered  in  1880  by  
Pierre  Curie.  The  ultrasound  is  generated  by  Piezo  electric  crystals  
like  quartz  or  a  synthetic  ceramic  material.  It  is  the  generation  of  
electric  voltage  when  a  crystal  is  compressed  or  stretched.  The  
reverse  piezo  effect  is  the  voltage  induced  compression  or  
expansion  of  crystal.  An  ultrasonic  beam  is  a  series  of  longitudinal  
waves  which  transmit  energy.  The  longitudinal  wave  is  propagated  
by  multiple  particles   (molecules  oscillating  back  and  forth  to  
produce  bands  of  compression  and  rarefaction  in  the  conducting  
medium).  When  these  bands  are  scattered  back  to  the  piezo  
electric  crystal,  they  change  the  crystal‟s  thickness  which  
produces  an  electric  signal.  This  signal  forms  the  basis  of  A-
mode  (Amplitude  Modulation)  displays  and  one  dimensional  static  
image  showing  echoes  as  spikes  projecting  from  a  baseline. 
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M  -  mode  (Motion  Displays)  records  the  echoes  as  dots. 
B  -  mode  (Brightness  Modulation)  is  a  two  dimensional  
display  of  the  image  produced,  by  moving  a  transducer  
either  longitudinally  or  in  cross  section. 
In  Grey  Scale  imaging  the  echoes  are  displayed  in  
various  shades  of  grey  depending  on  whether  it  is  weak  or  
strong.  Weak  echoes  are  displayed  as  light  grey  and  strong  
ones  are  displayed  as  dark  grey  or  black.  The  grey  scale  
allows  visualization  of  the  fine  internal  consistency  of  soft  
tissue  and  the  recognition  of  abnormal  patterns  characteristic  
of  diffuse  pathology. 
Real  time  imaging: 
To  study  the  dynamic  action  of  moving  structures  the  
real  time  imaging  is  used.  It  detects  and  displays  motion  as  it  
occurs.  A  frame  rate  of  15  seconds  or  greater  is    adequate.   
Two  scanning  techniques  provide  real  time  imaging. 
They  are: 
Mechanical  real  time  scanners  (sector) 
Multi  element  transducer  assay  (Linear  array) 
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TRANSVAGINAL   SONOGRAPHY  : 
High  -  resolution  Transvaginal  Sonography  (TVS)  is  being  
widely    used  since  the  mid-1980s.  It  has  gained  acceptance  as  
an  integral  part  of  gynecologic  and  early  obstetric  sonographic  
examinations
13
. 
Development  of  Trans  Vaginal  Sonography 
The first stage of evolution was the so called  A-mode technique. It 
used vertical deflections on a cathode ray to display the results. This 
first stage of TVS is connected with the name of „Kratchowil‟. In 1969, 
Kratchowil reported a new method of vaginal ultrasound  imaging the so 
called compound technique. 
Advantages  of  Transvaginal  sonography: 
1. Direct  access  to  the  pelvis  -  the  transvaginal  approach  
bypasses  attenuating  tissue  and  allows  a  high  frequency  
probe  to  be  placed  close  to  the  “target  organs”. 
2. Empty  Bladder  technique  -  discomfort  of  full  bladder  
associated  with  abdominal  ultrasound  is  avoided. 
3. Maximal  information: 
a. In  obesity 
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b. With  adhesions 
4. In  depth  of  the  pelvis  Dynamic  examination  methodology 
5. Detailed  imaging  of  internal  structures.   
Disadvantages: 
1. It  has  got  a  limited  field  of  view, 
2. Cannot  be  performed  on  virginal  patients  and  who  do  not  
willingly  consent  to  vaginal  examination
28
. 
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PERFORMANCE  OF  EXAMINATION 
For  transvaginal  sonography  an  empty  bladder  is  
preferred.  Scanning  is  performed  with  the  patient  in  supine  
position  with  knees  flexed.  Buttocks  may  be  elevated  by  using  
pillows.  Partial  lithotomy  position  can  also  be  employed. 
Probe  preparation 
The  probe  should  be  covered  with  a  condom  
containing  a  small  amount  of  coupling  gel.  Once  the  
transducer  has  been  covered,  additional  gel  placed  outside  the  
sheath. 
Examination  technique 
The  probe  is  inserted  into  the  vagina,  the  scan  is  
performed  through  the  anterior  vaginal  wall,  anterior  formix,  
lateral  fornices  and  the  cul-de-sac.  The  orientation  of  the  probe  is  
controlled  by  probe  rotation  and angulation. 
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Three  basic  scanning  maneuvers  are  performed  to  achieve  
appropriate orientation:18 
The  probe  can  be  rotated  from  0  to  90  degrees  about  its  
long  axis  to  obtain  any  plane  of  scan  from  sagittal  to  coronal. 
The  probe  can  be  angled  or  pointed  in  any  direction  
(within  the  limitations  of  vaginal  discomfort)  to  direct  the  plane  
of  section 
The  probe  can  be  advanced  or  withdrawn,  which  will  move  
adjacent  pelvic  viscera  and  displace  bowel,  and  allow  structures  
to  be  placed  in  the  focal  zone  of  the  transducer. 
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Difference   between  transvaginal (TVS)   and  transabdominal  
ultrasound(TAS)  (sautter) 
Features TVS TAS 
Penetration  (cm) 8 13-18 
Ultrasound  frequency  (MHz) 5-10 3-5 
Image  quality Better - 
Resolution Higher - 
Nature  of  study Dynamic Static 
Condition  of  study Empty  bladder Full  bladder 
Visibility  of  pelvis Blind  spots 
Present 
Blind  spots 
absent 
Organ  representation More  accurate - 
Organ  Assignment Better - 
Internal  structure In  detail - 
Diagnostic  benefit  in  pelvis Greater - 
Diagnostic  benefit  outside  the  
pelvis 
Not  available Excellent 
Acceptance Lesser Higher 
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Transvaginal  sonography  appearance  of  endometrial  changes  in  
normal  cycle: 
Phases  of  cycle Endometrial  morphology  in  
TVS 
Early  proliferative phase   
(day 4 -7) 
Linear, homogenous  echo.  
Endometrial  thickness  is  4mm  
Mid-proliferative phase  
(day 8 – 10) 
Endometrium  gets  thicker,   echo-
poor  zones  appear  on  both  
sides  of  a  linear  echo rich 
median  stripe.  Endometrial  
thickness  is  6mm 
Late  Proliferative  phase  
(day 11  –  14 ) 
Loop  shaped  endometrial  
structure.  Endometrial  thickness  
is  8mm 
Ovulatory  phase Annular  structure  appears.  
Endometrial  thickness  is  10mm 
Mid  secretory  phase Dense  echo,  reflection  rich  
again  piled  up  higher.  
Endometrial  thickness  is  12mm. 
Late  secretory  phase  Endometrial structure  disappears  
Endometrial  thickness  is  13mm.  
Pre  menstrual  (day 26 – 28)  Echo-poor  margin  appears.  Echo  
free  zone  in  the  uterine  cavity  
appears  Endometrial  thickness  
is  14mm 
Menstruation Unrecognized endometrial  echo    
in  the  diffuse  reflections. 
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Various  uterine  pathologies  in  Sonography  and  HPE
30
: 
Findings Sonographic  Criteria Histologic  Criteria 
Polyp 
 
 
 
Hyperplasia 
 
 
 
Myomata 
 
 
Atrophy 
 
 
Cancer   
Hyperechoic  regular  
mass  in  the  uterine  
cavity 
  
Regular endometrial  
thickness  more  than  
12mm 
 
 
 
Hyper or  hypoechoic  
rounded,  well defined 
myometrial  structures   
 
Endometrial thickness  
<4mm  
 
Irregularly  thickened  
endometrium  of  variable  
echogenic  texture 
Cystically  dilated  glands  
with  thick  walled  
vessels  in  a  fibrous  
stroma 
Endometrial  glandular  
twists  with  cellular    
secretory    activity    
without  cytonuclear  
abnormalities 
 
Smooth  muscle  tumour 
 
 
 
Disappearance    of    the    
endometrial  glands 
 
Cytologic      nuclear      
abnormalities  with  
structural  disorders. 
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Saline    Infusion  Sonohysterography  (SIS) 
Saline  infusion  sonography  is  otherwise  called  saline  contrast  
sonography  or  saline  infusion  sonohysterography.  It    is    a  technique  
where  a  catheter  is  placed  into  the  uterine  cavity  through  the  
cervical  os.  Sterile  saline  of about 10 to 20 ml is  injected  into  the  
endometrial  canal.  The  saline  distends  the  cavity.    Abnormalities  
such  as  endometrial  polyps  and  intracavitary  fibroids  can  be  easily  
delineated.  It  has  proved  to  be  as  reliable  as  visual  
inspection  in  describing  intracavitary  abnormalities.31 
Saline  Infusion  Sonohysterography  (SIS)    is    an    innovative  
technique    in  evaluating  a  variety  of  endometrial  and  myometrial  
lesions,  which  involve  the  endometrial  canal.  The  most  
common  indication  for  SIS  are  AUB  in  both  pre  and  post  
menopausal  women. 
Other  indications  include:18 
1. Infertility 
2. Recurrent  pregnancy  loss 
3. Congenital  anomalies  of  uterine  cavity 
4. Suspected  adhesions  of  the  uterine  cavity   
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5. Screening  before  In  Vitro  Fertilisation 
6. Post menopausal  bleeding.   
 Benign  endometrial  polyps  appear  well-defined.  They  are  
uniformly  homogeneous  or  hyperechoic.  With  Saline  infusion  
sonography,  the  endometrial  thickness  can  be  measured  
separately  from  the  polyp
32
.  Polyps  appear  as  protrusions  into  the  
cavity  when  examined  at  their  stalks,    otherwise  they  appear  as  
balls  of  endometrial  tissue  surrounded  by  saline.  It  is  important  
to  note  the  number  of  polyps,  their  size,  site,  margin  and  
areas  of  increased  echogenicity.  Colour  Doppler c a n  show  the  
vascularity    of  pedicles  and  can  demonstrate  atypical  blood  flow  
pattern.  This  might  suggest  malignancy,    though  it  is  not  specific  
or  sensitive  enough  to  rely  in  diagnosing  malignancy.
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With  conventional  TVS,  it  is  difficult  to  locate  fibroids  
exactly.  This  is  because  they  transmit  sound  poorly.  They  
attenuate  the  sound  beam  and  have  ill-defined  borders.  Fibroids  
may  obscure  endometrial  measurements  when  only  TVS  is  
used  as  they  create  an  irregular  interface  between  the  
myometrium  and  endometirum.  Fibroids  may  vary  in  appearance.  
They  may  have  calcified,  hypoechoic,  echogenic  or  isoechoic  
and  mixed  echogenic  patterns.  Degenerating  fibroids  often  
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appear  cystic.  SIS  helps  in  classifying  fibroids  early  and  
accurately  by  location,  size  and  degree  of  intramural  extension.  
They  can  be  evaluated  for  hysteroscopic  resectability.  This  is  
a  major  advantage  because  the  ability  to  resect  intracavitary  
fibroids  completely  will   affect  both  clinical  outcome  and  
surgical  complications. 
Following  is  the  classification  of  intracavitary  uterine  
fibroids  on  the  basis  of  SIS  for  the  purpose  of  planning  
surgery. 
Class  1  fibroids  -   Intracavitary  and  do  not  involve  
the  myometrium.  The  base  or  stalk  is  visible  with  SIS. 
1. Class  2  fibroids  –  They  have  a  submucosal  component  
which  involves  less  than  50%  of  the  myometrium. 
2. Class  3  fibroids  –  They  have  an  intramural  component  
greater  than  50% .  It  may  be  transmural  and  located    
anywhere    from  the  submucosa  to  serosa.  They  often  
appear  as  a  bulge  or  indentation  into  submucosa  when  
viewed  hysteroscopically. 
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Class  1  or  2  fibroids  can  be  resected  successfully    using  
hysteroscope    by    an  experienced  and  skilled  surgeon.  Class  3  
fibroids  are  less  amenable  to  hysteroscopic  surgery  because  of  a  
significant  probability  of  perforation,  fluid  overload,  contracture  of  
the  endometrial  cavity  and  incomplete  resection
29
. 
The    endometrial    thickness  of    each    wall  can  be  measured 
separately.  This  helps  in  identifying  focal  thickening  which  could  
be  specifically  biopsied  at  hysteroscopy.  The  surface  of  the  
endometrium  should  be  examined  for  irregularities.   
Heterogeneity  of  the  endometrium,  irregularity  of  the  
junction  between  the  myometrium  and  endometrium,  poor  
distention  of  the  uterine  cavity  on  injecting  saline  and  uniform  
increased  echogenicity  of  the  endometrium  should  raise  the  
suspicion  of  malignancy.18 
Endometrial  cancer  can  be  suspected  when  the  
endometrium  is  irregular,  has  mixed  echogenicity,  has  irregular  
borders,  demonstrates  endomyometrial  interface  disruption
23
.   
Most  studies  report  that  the  endometrium  is  thicker    in    
patients  subsequently  found  to  have  malignant  endometrial  
pathology  than  in  patients  with  benign  conditions.  An  
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endometrial  echo  of  less  than  4  mm  wi l l   be   rarely  
associated  with  endometrial  cancer.  In  most  of  the  endometrial  
cancers,  the  thickness  is  greater  than  4.7mm. 
Scheduling  the  Saline  Infusion Sonohysterography
33
: 
The  patient  should  be  examined  when  there  is  the  best  
chance  of  making  the  most  specific  /  sensitive  diagnosis.  Ideally  
SIS  is  scheduled  when  the  endometrium  is  thinnest,  most  
homogenous. 
In  premenopausal  women,  SIS  is  performed  in  the  
proliferative  phase  (first  half)  of  menstrual  cycle.  If  possible  it  
is  optimal  to  wait  until  the  bleeding  has  stopped  because  blood  
clots  can  be  confused  for  focal  lesions.  
In  post  menopausal  women,  if  patient  is  on  HRT,  then  
SIS  should  be  scheduled  approximately  6  days  after  the  last  
progestin  pill  when  endometrium  is  thinnest.  If  HRT  not  taken,  
can  be  scheduled  at  any  time. 
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Advantages  of  Saline  Infusion  Sonoography  as  compared  with  
hysterosalphingography: 
 SIS  offers  several  advantages  over  conventional HSG (hystero  
salphingography). 
1. No  ionising  radiation. 
2. Does  not  require  an  expensive fluroscopic/ radiographic  dye  
which  eliminates  the  small  risk  of  anaphylactic  reaction  to  
these  agents  if  there  is  intravasation. 
3. SIS  is  less  uncomfortable  than  HSG  as  in  later  there  is  
quick  distension  of  endometrial  cavity  after  blocking  the  
cervix  which  leads  to  painful  cramping,  but  with  SIS  there  
is  slow  gradual  distention  and  the  extra  fluid  can  leak  out  
thus  decreasing  the  incidence  of  painful  cramping. 
4. SIS  allows  for  visualization  of  myometrium,  external  contour  
of  uterus  and  adnexae. 
Disadvantages  of  SIS: 
1. Tubal  anatomy  is  not  visualised  with  SIS.  Tubal  patency  
can  be  inferred  by  demonstration  of  fluid  appearing  in  the  
cul-de-sac  after  saline  instillation,  but  it  does  not  indicate  
which  of  the  tubes  in  patent. 
2. Risk  of  infection 
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3. Eventhough  SIS  correctly  evaluates  the  depth  of  myometrial  
invasion,  chances  of  spread  of  malignant  cells  into  the  
peritoneum  is  present  in  case  of  endometrial  carcinoma
33
. 
Diagnostic  pitfalls: 
Passage  of  Catheter: 
Sometimes  there  may  be  difficulty in introducing  the    
intrauterine    catheter.  This  is  more  common  in  case  of  previous  
cervical  surgeries.    Initial  passage  of  t h e    sound  usually  
resolves  these  difficulties. 
Analgesia: 
It  is  a  simple  procedure  and  does  not  require  any  
analgesia  except  in  some  patients  who  might  have  colicky  pain  
during  or  after  the  procedure.  They  can  be  given  simple  NSAID  
like  tablet  Diclofenac    half  an  hour  prior  to  the  procedure. 
Inadequate  distension  of  cavity 
In  certain  cases  where  there  is  a  patulous  cervix  adequate  
quantity  of  fluid  may  not  be  retained    to  distend  the  cavity.  In  
such  cases  it  is  better  to  use  the  bulb  of  the  Foley‟s  catheter  
instead  of  using  other  plastic  catheters  and  intra  uterine  
insemination  catheters. 
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Contraindications t o  S I S   : 
Although  SIS  is  in  general  a  safe  procedure    with    little  
discomfort,  there  are  several  contraindications  to  it: 
   
i. Possible    pregnancy,    to    avoid    the    possibility    of    
disrupting    an    implanting  gestation. 
ii. Infection  or  pelvic  pain  suggestive  of  pelvic  
infection  to  avoid  exacerbating  the  symptoms. 
iii. Intractable    cervical    stenosis,    which    would    make    
insertion    of  a   catheter  difficult  and  uncomfortable.28 
iv. Diagnosed  cases  of  endometrial  carcinoma. 
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Transvaginal Ultrasound – showing a normal endometrial cavity 
 
 
 
 
 
 
 
 
 
SIS  on the same  patient- showing  normal uterine cavity 
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Trans  vaginal  sonography  –showing  intramural  myoma 
 
 
 
 
 
 
 
Saline  infusion  sonography  –  showing  submucous  myoma 
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METHODOLOGY 
This    prospective    study  was  conducted  on  100  inpatients  
in    the  department  of  Obstetrics  and  Gynecology,  Coimbatore  
Medical  College  Hospital,    Coimbatore.  The  Ethics  committee  of    
the  hospital  has  approved  the  study.  Informed  consent  was  obtained  
from  all  the  patients.   
The  study  included  patients  in  reproductive  age  group  with  
complaints  of  abnormal  uterine  bleeding,  in  the  form  of  
menorrhagia,  metrorrhagia  and  polymenorrhoea    who  underwent  
hysterectomy. 
A  detailed  history  was  taken,  with  special  emphasis  on  
menstrual    history.    Specific  history  was  asked  to  rule  out  the  
systemic  disorders  responsible  for  abnormal  uterine  bleeding.  
Thorough  clinical  examination  was  carried  out  including  breast,   
thyroid  and  pelvic  examination.  Relevant   laboratory  
investigations  were  done.  All  the  patients  were  then  subjected  to  
sequential  evaluation  with  TVS  and  SIS  before  hysterectomy  was  
done. 
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All  TVS  examinations  were  performed  first  using  endovaginal    
probe  of  7.5  MHz  (covered  by  a  condom).  The  patient  was  asked  
to  empty  the  bladder  before  the  procedure  and  then  placed  in  
dorsal  position  with  knees  flexed  a  little.  TVS  was  used  to  
examine  both  ovaries  and  the  uterus.  The  uterus  was  scanned  in  
the  sagittal  and  coronal  planes  for  the  presence  of  myometrial  
masses,  and  the  endometrium    was  examined  for  an  endometrial  
pathology.  The  endometrial  thickness    was  measured    at  the  widest  
point  between  the  endometrial  –  myometrial    interfaces  in  the  
sagittal  plane.  The  presence  of  focal  endometrial  thickening  or  a  
focal  mass  was  noted. 
The  cervix  was  swabbed  with  the  povidine-iodine  
solution.  No.8  Foley‟s  catheter  was  placed  in  the  cervix  and  
the  balloon  inflated  with  1.5  to  2  ml  of  distilled  water  such  
that  it  lies  just  above  the  internal  os.  This    blocks  the  
distension  fluid  from  flowing  out  from  the  endometrial  cavity.  
Speculum  was  removed  and  the  vaginal  probe  (covered  by  a  
condom)  was  reinserted. 
Sterile  saline  was  infused  gently  until  the  distension  of  the  
uterine  cavity  was  adequate  to  see  any  lesion  or  till    pain  appears  
and  the  findings  were  noted.  Saline  acts  as  a  contrast  that  fills  the  
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uterine  cavity.  Uterine  cavity  was  visualized  in  longitudinal  plane  
from  one  ostia    to  the  other  and  in  coronal  plane  from  fundus  
to  endocervix. 
The  endometrial  cavity  was  examined  for  the  presence    of   
polyps  or  submucosal  myoma.  Any  projection  inside  the  uterine  
cavity  was  observed    with  special  attention  to  its  shape  and  
echnogenicity.  Evidence  of  abnormal  endometrial  thickening  was  
also  noted.  The    balloon    was    deflated    and    the    catheter    
gently  removed. 
The  hysterectomy  specimen  was  examined  both  grossly  and  
histopathologically.  Findings  were  compared  with  that  of    TVS  and  
SIS. 
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SELECTION  CRITERIA 
(a) Inclusion  Criteria   
1.Women  presenting  with  abnormal  uterine  bleeding  such  as  
menorrhagia,  metrorrhagia,    menometrorrhagia    and  polymenorrhea  
in  the  reproductive  age  group  and  perimenopausal  age  group, who 
were posted for hysterectomy, after failure of all the medical measures. 
(b) Exclusion  Criteria   
1. Postmenopausal  women, 
2. Women  with  evidence  of  systemic  disease   
3. Evidence  of  pregnancy, 
4. Evidence  of  PID 
5. Previous  H/O  uterine  surgery,  cervical  surgery, 
6. Endometrial  biopsy  within  the  previous  one  year, 
7. Puberty  menorrhagia, 
8. Unmarried  women. 
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OBSERVATIONS AND RESULTS 
The  study  was  conducted  in  Coimbatore  medical  college  
hospital  from  July 2014  to  July  2015.   In  this  study  hundred  
patients  who  were  being  subjected  to  hysterectomy  for  AUB  were  
analysed.  It  was  made  sure  that  they  were  fulfilling  the  inclusion  
and  exclusion  criteria.  The  women  who  had  any  evidence  systemic  
diseases  such  as  diabetes,  hypertension,  PCOS,  thyroid  disorder,  
evidence  of    endometriosis  were  not  taken  into  the  study. 
In  three  cases  there  was  difficulty  in  passing  the  cathter  for  
saline  infusion  as  the  patients  complained  of  pelvic  discomfort.  The  
procedure  was  stopped  for  some  time.  They  were  given  analgesic  
injection  and  then  the  study  was  resumed.  In  five  cases  there  was  
leakage  of  the  injected  saline.    There  the  procedure  was  completed  
with  difficulty.     
Mean  age  of  the  patients  taken  in  the  study  is  42.17  years   
(  range  28  to  51  ).  Mean  duration  of  the  symptoms  is  8.8  months  
(range  1  to  36  ).  The  observations  are  tabulated  in  the  following  
pages.   
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TABLE  –  1 AGE  WISE  DISTRIBUTION 
        
According  to  this table  all  patients  in  the  study  group  belong  
to  the  reproductive   and  perimenopausal  age  group.  
 
AGE GROUP OF THE PATIENTS 
Number Minimum Maximum Mean 
100 36 53 43.81 
 
 
 
 
 
 
Age  (years  ) Frequency Percent 
36-40 8 8% 
41-45 39 39% 
46-50 41 41% 
>50 12 12% 
TOTAL 100 100% 
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GRAPH    -    1   
 
 
Maximum  number   of  patients are  in  the  age  group  41 – 45 
and  46 – 50 years. 39% in the first and 41 % of patients are there in the 
second   group.   
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TABLE  –  2 
DISTRIBUTION    ACCORDING  TO  PARITY 
Parity Frequency Percent 
P1 3 3% 
P2 22 22% 
P3 37 37% 
P4 25 25% 
P5 7 7% 
P6 6 6% 
Total 100 100% 
 
 37 % of the  patients  had  delivered thrice.  25% patients had 4 
children  and  22% patients had  2 children. 
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GRAPH  -  2
 
 
According  to  this  graph  greater  incidence  of  AUB  was  noted  
in  multiparas.  Among  the  100  women,  none  were  nulliparous. 
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TABLE  –  3 
DISTRIBUTION  OF PATIENTS ACCORDING  TO DURATION 
OF  SYMPTOMS 
Duration(months) Frequency Percent 
1-3 8 8% 
4-6 37 37% 
7-9 30 30% 
10-12 15 15% 
24 7 7% 
36 3 3% 
Total 100 100% 
   
 This  table  reveals  that  37%  of  patients had symptoms for 4 to 6  
months  of duration and another 30 % had symptoms for 7 to 9 months. 
  
DURATION OF SYMPTOMS (YEARS) 
Number Minimum Maximum Mean Std.deviation 
100 1 36 8.8 6.98 
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GRAPH  –  3 
DISTRIBUTION  OF PATIENTS ACCORDING  TO DURATION 
OF  SYMPTOMS 
 
 
 
In  maximum  number  of  patients   duration  of  symptom  was  
between  4-6  months  with  a  range  of  1  month  to  3  years. 
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TABLE  –  4 
DISTRIBUTION  ACCORDING  TO  DIAGNOSIS  ON  TVS 
Findings Frequency Percent 
Endometrial hyperplasia 24 24% 
Intramural  myoma 15 15% 
Submucous  myoma 17 17% 
Endometrial  polyp 6 6% 
Normal 38 38% 
Total 100 100% 
  
 In  24%  of  patients  endometrial hyperplasia  was  noted.  15%  
had intramural  myoma,  17%  had  submucous  myoma  and  6%  had  
polyp. 
GRAPH    -  4
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TABLE  –  5 
DISTRIBUTION  ACCORDING  TO  DIAGNOSIS  MADE  ON  SIS 
Findings Frequency Percent 
Endometrial  hyperplasia 20 20  % 
Intramural  myoma 13 13  % 
Submucous  myoma 19 19  % 
Endometrial  polyp 8 8  % 
Normal 40 40  % 
Total 100 100% 
 
 SIS  diagnosed  20  %  of  patients  as  having  endometrial  
hyperplasia,  19%  as  submucous  myoma  and  13%  as  intrmural  
myoma. 
GRAPH  –  5  
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TABLE    -    6 
DISTRIBUTION  ACCORDING  TO  THE  DIAGNOSIS  BASED  
ON  THE  HISTOPATHOLOGICAL  EXAMINATION 
Findings Frequency Percent 
Endometrial  hyperplasia 18 18  % 
Intramural  myoma 14 14  % 
Submucous  myoma 19 19  % 
Endometrial  polyp 8 8  % 
Normal 40 40  % 
Endometrial  carcinoma 1 1  % 
Total 100 100  % 
    
Histopathological examination included both gross and  
microscopic  examination  of  the  uterine specimen after hysterectomy 
and it was  considered  the  gold  standard.   
 
 
 
 
60  
GRAPH    -    6 
 
 
 Gross  and  microscopic  examination  of  the  hystrectomised  
specimen has  shown  endometrial  hyperplasia  in  18 % of cases,  
submucous  myoma  in  19% ,  intramural  myoma  in  14 %  and  
endometrial  polyp  in  8 %  of the cases. In  40 %  of  the  cases  it  was  
a  normal  uterus. 
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TABLE    -    7 
COMPARISON  OF  THE    DIAGNOSIS    BY  THE  3  
INVESTIGATION  MODALITIES 
Diagnosis TVS SIS HPE 
Endometrial  hyperplasia 24 20 18 
Intramural  myoma 15 13 14 
Submucous  myoma 17
 
19 19 
Endometrial  polyp 6 8 8 
Normal 38 40 40 
Endometrial  carcinoma 0 0 1 
Total 100 100 100 
 
TVS  findings  did  not  correlate  with  that  of    the  final  
diagnosis  in  36  cases.  The  18  false  negative  diagnosis  included  3  
endometrial  hyperplasia,  5  submucous  myoma,  4  intramural  myoma,  
3  endometrial  polyps,  1  endometrial  carcinoma  and  2  cases  of  
normal  uterus.  In  18  cases  the  results  of  TVS  were  false  positive .  
They  were  9  endometrial  hyperplasia,  3  submucous  myoma,  5  
intramural  myoma  and  1  case  of    endometrial  polyp.  
SIS  findings  did  not  correlate  with  that  of    the  final  
diagnosis  in  16  cases.  The  8    false  negative  were  2  endometrial  
hyperplasia,  2  submucous  myoma,  2  intramural  myoma  ,1  
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endometrial  polyp  and  1  case  was  carcinoma of  the  endometrium .  
In  8  cases the  results  of  SIS  were  false  positive.  They  were  4  
endometrial  hyperplasia,  2  submucous  myoma,  1  intramural  myoma  
and  1  case  of  endometrial  polyp.  
1  case  of    endometrial  carcinoma  was  falsely  diagnosed  as  
endometrial  hyperplasia  by  both    the  imaging  modalities  namely    
TVS  and  SIS.   
The    commonest    HPE    finding    noted    was    submucous  
myoma    followed    by    endometrial    hyperplasia,    whereas    the    
commonest  findings    on    TVS    and    SIS    were    endometrial    
hyperplasia    followed    by    submucous    myoma.   
These    variations    in    the    diagnoses    are    depicted    in    the    
following    two    graphs. 
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GRAPH    7 
ASSOCIATION  OF  DIAGNOSIS  MADE  BY  TRANSVAGINAL  
SONOGRAPHY  VS  HISTOPATHOLOGY 
    
 
 The  sensitivity  of  TVS  is  83%  for  endometrial  hyperplasia,  
71%  for  intramural  myoma,  74%  for  submucous  myoma  and  63%  
for  endometrial  polyp.    
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GRAPH    -    8 
ASSOCIATION  OF  DIAGNOSIS  MADE  BY  SALINE  
INFUSION  SONOGRAPHY  VS  HISTOPATHOLOGY 
 
 
 
The  sensitivity  of  SIS  is  89%  for  endometrial  hyperplasia,  
86%  for  intramural  myoma,  89%  for  submucous  myoma  and  88%   
for  endometrial  polyp. 
 
 
End. 
Hyperplasia
I.m. myoma S.m. myoma Normal End. Polyp
SIS sis sis sis sis
End. Hyperplasia[n=18] 89% 0% 11% 0% 0%
I.m. myoma[n=14] 14% 86% 0% 0% 0%
S.m. myoma[n=19] 0% 5% 89% 0% 5%
Normal[n=40] 0% 0% 0% 100% 0%
End. Polyp[n=8] 13% 0% 0% 0% 88%
Enometrial Ca[n=1] 100% 0% 0% 0% 0%
0%
20%
40%
60%
80%
100%
120%
Association of SIS Vs HPE [N=100] [p=<0.001]
65  
TABLE    -    8 
DIAGNOSTIC    PERFORMANCES    OF    TVS    AND    SIS    IN    
IDENTIFYING    VARIOUS    CAUSES    OF    AUB 
Diagnosis 
Test  
performance 
Endometrial  
hyperplasia 
Submucous  
myoma 
Intramural  
myoma 
Endometrial  
polyp 
TVS SIS TVS SIS TVS SIS TVS SIS 
Senitivity    
% 
83.33 88.89 73.68 89.47 71.43 85.71 62.5 87.5 
Specificity  
% 
89.02 95.12 96.30 97.53 94.19 98.84 98.91 98.92 
Positive  
predictive  
value  % 
62.50 80.00 82.35 89.47 66.67 92.31 83.33 87.50 
Negative  
predictive  
value    % 
96.05 97.50 93.98 97.53 95.29 97.70 96.81 98.20 
 
From    the    above    table    it  is    evident    that    sensitivity,    
specificity,    positive      predictive    value    and    negative    predictive    
value    were  all    greater    for    SIS    compared    to    that    for    TVS.   
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TABLE    -    9 
OVERALL  STATISTICAL  PERFORMANCES  OF  TVS  AND  SIS 
Statistical  performance TVS SIS 
Sensitivity    % 72.74 87.89 
Specificity    % 94.61 97.60 
Positive  predictive  value  % 73.71 87.32 
Negative  predictive  value  % 95.53 97.73 
 
Again    it  is  proved    that    SIS    has    a    higher    sensitivity,    
specificity,  positive  and  negative  predictive  value  compared  to  TVS. 
All  the  statistical  analyses  were  performed  using  a  statistical  
software  package  ( SPSS  Version  16  for  windows ).  A  p value  of  
<0.05  using  a  two  -  tailed  test  was  taken  as  being  of  significant  
for  all  statistical  tests. 
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DISCUSSION 
Abnormal  uterine  bleeding  is  an  important  and  common  
problem  suffered  by  woman  of  any  age  group  not  only  from  
menarche   to  menopause,  but  also  after  menopause.  Heavy  
menstrual  bleeding  is  the  abnormal  bleeding  that  has  an  impact  on  
the  woman‟s  quality  of  life.  It  may  affect  the  woman  physically  
and  emotionally  restraining  her  from  daily  activities,  or  socially  
being  the  reason   for  her  absence  in  workplace.  It  may  also  affect  
the  woman‟s  material  quality  of  life.   
As  mentioned  earlier  the  causes  of  abnormal  uterine bleeding  
vary  depending  on  the  age  of  the  patient.  Investigations  should  be  
chosen  promptly  keeping  in  mind  the  commonest  causes.  After  the  
initial  investigations  to  know  the  general  condition  of  the  patient,  
there  comes  the  specific  investigations  to  identify  the  exact  
pathology  responsible  for  the  abnormal  bleeding.  Imaging  modalities  
play  an  important  role  here  before  the  endometrial  sampling  
methods.  
Transvaginal   ultrasonography  is  being  perfomed  as  an  initial 
investigation  modality  in  the  evaluation  of  uterine  pathologies  
responsible  for AUB.  It  can  be  performed  easily  in  the  outpatient  
setting  itself.  No  premedication  or  anaesthesia  is  required.  There   is  
68  
no need  for  prior cervical dilatation.  Since  a  sterile  condom  is always  
used  to cover  the  transvaginal  probe  the  chance  of  infections  is  
very  minimal  or  almost  nil.  The  images  can  be  saved  for  future  
references.  
Saline  infusion  sonography  is  one  step  ahead  of  trans  vaginal  
sonography  where  sterile  saline  infused  through  the  cathter  acts  as  
a  contrast  medium  inside  the  uterine  cavity.  The  endometrial  
intracavitary  pathologies  which  may  be  difficult  to  diagnose  by  
TVS  could  easily  be  differentiated  with  the  use  of  SIS.   
Diagnostic   hysteroscopy   has   become   an   acceptable   
modality   of   investigation   to   visualize   the   uterine   cavity   and   
perform   biopsy   in   the   same   sitting   if   necessary.   However   this   
is   an   invasive   procedure,   costlier   than  sonography   and   requires   
a   more   complicated   setup.   In   a   developing   country   like   India   
this  is   still   not   available   to   every   patient.   
Hence  the  present  study  was  conducted  to  find  out  and  
compare  the  diagnostic  effectiveness  of  TVS  and  SIS.  Various  
studies  have  already  been  done  in  small  scale  and  also  in  large  
scale  comparing  the  two  modalities. 
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DISTRIBUTION   OF  PATIENTS  ACCORDING  TO  AGE 
The  mean  age  of  the  patients  in  this  study  was  43.81 years  
with  a  range  of  36 to 53  years.  Maximum  number  of  patients  are  in  
the  age  group  of  41 to 45 and  46  to  50  years.  That  is  in  the  
reproductive  age  and  perimenopausal  age  group.  In  the  study  by  
Saidi  et  al 
33
  age  group  taken  was  40 to 89  years.  Mean  age  of  
patients  in  the  study  by  Reddi  Rani  P  and  Lakshmikantha  G
8
  was  
45.56  years  and  in  that  by  Muhammad  Aslam  et  al
16 
 was  38.3 ± 9.6  
years  (range  25  to  68  years).  All  other  studies  also  had  women  of  
reproductive, perimenopausal  and  postmenopausal  age  group.  
NUMBER  OF  PATIENTS  IN  DIFFERENT  STUDY  GROUPS  
Authors No  of  patients 
Reddi  Rani  &  Lakshmikantha 52 
Muhammad  Aslam  et  al 100 
Saidi  et  al 68 
Present  study 100 
  
The  number  of  patients  in  different  study  groups varied.  In  
the  present  study  100  patients  were  taken  for  analysis. 
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The  duration  of  symptoms  ranged  from  less  than  6  months  to  
upto  3  years.  Maximum  number  of  patients  had  complaints  within  
4  to  6  months.  The  mean  duration  was  8.8  months  with  a  standard  
deviation    of    6.98. 
This  study  showed  that  SIS  has  higher  sensitivity  and  
specificity  when  compared  with  TVS.  Similar  findings  were  
observed  in  the  studies  by    Saidi  et  al  
34
,    Reddi  Rani  P  and  
Lakshmikantha  G
8  
  and    Muhammad  Aslam  et  al
16
.   
In  the  present  study  sensitivity  and  specificity  of   TVS   was  
72.74 %  and  94.61%.  Sensitivity  and  specificity  of  SIS  was  87.89 %   
and   97.6%.   The  positive  predictive  value  and  negative predictive  
value  of   TVS  was  73.71 %  and  95.53 %.  The  positive  predictive  
value  and  negative  predictive  value  of  SIS  was  87.32%   and  97.73 
%.  All  these  were  calculated  taking into account  histopathology   as  
the  final diagnosis. The association  was  calculated  using  chi  square  
test  and  was  statistically significant.  
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SUMMARY      OF    VARIOUS    STUDIES 
Study Procedure 
Sensitivity  
% 
Specificity  
% 
Saidi  et  al
34 
TVS 
SIS 
95.7 
90.9 
63.6 
83.3 
Reddi  Rani  &  
Lakshmikantha
8 
TVS 
SIS 
65.5 
82.0 
88.0 
95.0 
Muhammad  Aslam 
    et  al
16 
TVS 
SIS 
71.43 
92.86 
67.7 
89.65 
Present  study TVS 
SIS 
72.74 
87.89 
94.61 
97.60 
 
de    Kroon  et  al
35
    in  a  meta  analysis    made  review  of  
sixteen    different  studies  which    comprised  877  procedures.      The  
diagnostic  accuracy  was  compared  between    SIS  and  hysteroscopy    
in  the  women  presenting  with  AUB  in  the  perimenopausal  age  
group.  The  sensitivity  of  SIS  was  95%  in    the  evaluation  of  
uterine  cavity  and  it  also  showed  an  88%  of  pooled  specificity.   
The  sensitivity  and  specificity  of  SIS  and  TVS  was  different  
for  the  different  lesions.    Various  studies  have  also  confirmed  this.  
The  sensitivity    and    specificity    for    endometrial  polyp  was  70 %  
and  95.35%  for  TVS  whereas  it  was  90%  and  98.11%  for  SIS  in  
the  study    by  Muhammad  Aslam  et  al.  The  sensitivity  and  
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specificity  for  the  same  endometrial  polyp  was  71.4 %    and    97%  
in  the  study  by  Rani  Reddi  and  Lakhmikantha.  Similar  results  were  
obtained  in  our  study  also.   
With  regard  to  submucous  myoma,  the  sensitivity  and  
specificity  of    TVS  was  61.54  %  and  97.67  %  whereas  that  for  
SIS  was  100  %    both,  in  the  study  by  Muhammad  et  al.  27.3  %  ,  
85  %    for  TVS  and  81.8  %,  97  %    for    SIS,    the  sensitivity  and  
specificity    respectively  for  submucous  myoma  in  the  study  by  
Reddi  Rani  and  Lakshmikantha.  In  our  study  they  were  73.68  %    
and    96.30%    for  TVS    and    89.47  %  and  97.53%      for    SIS.  
Hence  it  is  evident  that  SIS    has    a  higher    sensitivity  and  
specificity  for  the  intracavitary  pathologies  compared  to  TVS. 
All  imaging  techniques  can  have  a  number  of  false  results  
even  in  the    experienced  hands.    It  may  be  because  of  the  large  
intra  mural  myomas  compressing  the  cavity,  hemorrhagic  debris,  
sessile  polyps,  and  polyps  arising  from  endocervix.    Sometimes  
even  the  bulb  of  the  foley‟s  catheter  may    compress  the  lesion.    
Ryu  et  al 
36
  noted  false  results  in  12 %  of  the  case.  These  were  
because  of  the  small  polyps  which  measured  less  than  5  mm,  
presence  of  uterine  synechiae  and  chronic  endometritis. 
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Three  patients  experienced  pelvic  discomfort  while  performing  
SIS  in  our  study.    In  the  study  by  Cicinelli  et  al
37
  severe  pain  was  
experienced  by  11 %  of  the  patients.    The  pain  may  be  due  to  
difficulty  in  passing  the  catheter  in  stenosed  cervix.  The  pain    due  
to  distension  of  the  uterine  cavity  can  be  minimized  if  saline  
instillation  is  controlled  and  stopped  as  soon  as  the  lesion  is  
detected. 
Rate  of  infection  following  the  procedure  could  not  be  found  
out  in  our  study  because  only  the  patients  posted  for  hysterectomy  
were  taken  into  the  study.  Hence  long  term  follow  up  could  not  be  
done.    However  in  a  review  by    Chung  et  al
38    
  of  900  procedures  
of  SIS,  an    infection  rate  of    0.6 %    was  observed.    Infection  rate  
of  about  1%  and  pelvic  pain  of    about    1 %  was  noted    in  the  
study  by  Bonnamy  et  al
39
.        
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LIMITATIONS 
Only  a  small  sample  size  was  taken.  Most  of  our  patients  
belonged    to  the    lower  socio  economic  status.  Hence  these  
findings  may  or  may  not  be  generalizable.    Inter  observer  variations  
are  possible.    Cases  were  selected  only  from  patients  posted  for  
hysterectomy  for  AUB  and  not  from  the  OPD.  Hence  the    results  
may  not  be  applicable    to  the  general  population  .     
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SUMMARY 
The  present  study  was  carried  out  in  100  patients  posted  for  
hysterectomy  for  AUB  in  Coimbatore  medical  college  hospital.   
The  patients  were  taken  up  for  sequential  examination  with  
transvaginal  sonography  and  saline  infusion  sonography  after  
obtaining  an  informed  consent. 
1. In  the  present  study,  the  age  of  the  patient  ranged  from  36  to  
53  years,  with  the  maximum  number  belonging  to  age  group  
41  to  45  years  and  46  to  50  years,  39 %  in  the first group and 
41% in the second group. 
2. Parity  of  the  patients  ranged  from  1  to  6.  Maximum  number  
of    patients  were  P3  (37  %). 
3. The  duration  of  the  symptoms  ranged  from  1  month  to  upto  3  
years.  Maximum  number  of  patients  had  complaints  for  4  –  6  
months  (37%). 
4. On  transvaginal  sonographic  evaluation,    endometrial  
hyperplasia  was  diagnosed  in  24%  cases,  submucous  myoma  in  
17%,  intramural  myoma  in  15%  and    endometrial  polyp  in  6%  
cases.  In  38%  of  the  patients  no  specific  abnormality  was  
found. 
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5. On  saline  infusion  sonographic  evaluation,    endometrial  
hyperplasia  was  diagnosed  in  20%  cases,  submucous  myoma  in  
19%,  intramural  myoma  in  13%  and    endometrial  polyp  in  8%  
cases.  In  40%  of  the  patients  no  specific  abnormality  was  
found. 
6. On  gross  and  microscopic  examination  of  the  hystrectomised  
specimen,    endometrial  hyperplasia  was  diagnosed  in  18%  
cases,  submucous  myoma  in  19%,  intramural  myoma  in  14%  
and    endometrial  polyp  in  8%  cases.  In  40%  of  the  patients  
no  specific  abnormality  was  found.  Endometrial  carcinoma  was  
noted  in  1%  of  the  patients. 
7. Endometrial  carcinoma  was  not  diagnosed  by  both  TVS  and  
SIS  in  our  study. 
8. The  sensitivity  of    TVS  was  72.74%,  specificity  was  94.61%,  
the  positive  predictive  value  was  73.71%  and  negative  
predictive  value  was  95.53%. 
9. The  sensitivity  of  SIS  was  87.89%,  specificity  was  97.6%,  the  
positive  predictive  value  was  87.32%  and  negative  predictive  
value  was  97.73%. 
10. The  association  between  TVS  and  SIS  was  statistically  
significant  [  chi  square  test,  p  value  <0.05]. 
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11. No  complications,  particularly  infection  occurred  with  saline  
infusion  sonography. 
12. In  3  patients  the  procedure  had  to  be  stopped  for  some  time  
as  the  patients  experienced  pelvic  pain. 
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CONCLUSION 
Transvaginal  sonography  and  saline  infusion  sonography  
together  is  a  very  sensitive  and  specific  technique  for  diagnosing  
any  intrauterine  abnormality  in  cases  of  AUB.  Both  are  simple,  
minimally  invasive  and  low  cost  technique.  SIS  outlines  the  uterine  
cavity.  Myoma,  polyp  or  endometrial  abnormality  missed  on  
transvaginal  ultrasound  alone  is  identified  accurately  with  this  
technique.  Hence  it  can  even  help  in  choosing  the  case  where  
hysteroscopy  and  directed  biopsy  is  required.  There are  no  
significant  complications  associated  with  SIS.  Therefore  we  
recommend  that  SIS  should  be  used  as  a  first  line  investigation  in  
the  evaluation  of  AUB  along  with  TVS.       
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ANNEXURE I 
 
PROFORMA 
 
Serial no : Hospital no : 
 
Name : D.O.A : 
Age : 
Address : 
 
I. CHEIF COMPLAINTS 
 
II. HISTORY OF PRESENTING COMPLAINTS: 
 
III. MENSTRUAL HISTORY: 
 
Age  of menarche 
Present menstrual cycle 
Duration of cycle : 
Amount of flow: 
Duration of flow: 
Associated dysmenorrhoea: 
Previous menstrual cycles- 
Duration of cycles: 
 
Amount of flow: 
 
Duration of flow: 
 
Associated dysmenorrhoea:  
Date of last menstrual period 
: 
iii) OBSTETRIC HISTORY: 
 
Married life :    no. of children : 
Para:   living:  abortion: 
Last child birth: 
 
V ) PAST HISTORY: 
 
Tuberculosis/ bronchial asthma/ diabetes mellitus/ hypertension/ thyroid 
disorder / any surgeries 
VI ) FAMILY HISTORY: 
 
Tuberculosis/ bronchial asthma/ diabetes mellitus/ hypertension/ any 
malignancy 
VII) PERSONAL HISTORY: 
 
Diet: 
Appetite: 
Bowel: 
Micturation: 
Sleep: 
GENERAL PHYSICAL EXAMINATION: 
 
Pallor,  icterus,  clubbing,  edema,  
lymphadenopathy,  cyaonsis. 
      
 Blood Pressure:     Height: 
 Pulse:      Weight 
 
BMI : 
Breast: 
Thyroid:  
Spine: 
Systemic examination  
Cardio vascular system: 
 Respiratory system:  
Abdominal examination: 
 Inspection 
 
 Palpation 
 
 Auscultation 
 
Per speculum examination:  
 
Per vaginal examination: 
 
 
 
 
 
 
 
 
 
 
INVESTIGATIONS 
 
Blood group, Rh   typing 
 Hb: PCV 
TC: DC: 
 
BT: CT: 
 
Platelets: 
FBS, 
PPBS: 
Urine routine:  
Pap smear: 
 
TVS and SIS findings: 
 
 Uterine size 
 
 Endometrial thickness 
 
 Any fibroid/ polyp/ septa 
 
 Adnexa 
 
COMPARISON AND COMMENTS: 
 
  
  
 
 
 
 
ANNEXURE II 
 
MASTER CHART 
S.NO IP NO NAME AGE PARITY 
DURATION 
OF 
SYMPTOMS 
(MONTHS) 
TRANSVAGINAL 
ULTRASOUND 
SALINE INFUSION 
SONOGRAPHY 
HISTO PATHOLOGY 
1 49834 Ramathal 41 P2 L2 9 Normal Normal  Normal 
2 48271 Subbammal 38 P2L2 7 I.m. myoma I.m. myoma I.m. myoma 
3 53823 Kalamani 46 P3L3 24 Normal Normal Normal 
4 57829 Saraswathi 49 P4L4 5 End. Hyperplasia Normal Normal 
5 58755 Baby 47 P4L4 4 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
6 52035 Shanthi 39 P2 L2 6 Normal Normal Normal 
7 62912 Sumathi 43 P3L3 8 Normal Normal Normal 
8 66617 Thamarai selvi 48 P4L4 4 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
9 60536 Nageshwari 28 P1L1 7 Normal Normal Normal 
10 63654 Thangamani 50 P6L6 1 S.m. myoma S.m. myoma S.m. myoma 
11 63616 Arulmozhi 41 P4L4 36 Normal Normal Normal 
12 64469 Ponnammal 38 P3L3 7 Normal Normal Normal 
13 68431 Savitha 48 P5L5 1 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
14 67493 Selvi 39 P2L2 4 End. Hyperplasia End. Hyperplasia I.m. myoma 
15 68462 Vasugi 42 P4L4 8 Normal Normal Normal 
16 68464 Saraswathi 33 P1L1 4 End. Hyperplasia Normal Normal 
17 70181 Devi 38 P3L3 5 I.m. myoma I.m. myoma I.m. myoma 
18 71732 Krishnaveni 40 P3L3 24 Normal Normal Normal 
19 71738 Ramathal 49 P5L5 5 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
20 74386 Saroja 39 P2L2 6 End. Polyp End. Polyp S.m. myoma 
21 72615 Maimoon 46 P4L4 11 Normal Normal Normal 
22 72652 Meenakumari 40 P3L3 12 I.m. myoma I.m. myoma I.m. myoma 
23 76868 Eswari 36 P2L2 11 Normal Normal Normal 
24 76939 Vimala 43 P4L4 6 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
25 80161 Alagammal 51 P6L6 9 Normal Normal Normal 
26 81981 Saraswathi 42 P2L2 9 S.m. myoma S.m. myoma S.m. myoma 
27 80964 Velammal 40 P3L3 8 Normal Normal Normal 
28 88372 Kamalaveni 39 P3L3 36 Normal Normal Normal 
29 83299 Parameshwari 45 P4L4 5 I.m. myoma I.m. myoma I.m. myoma 
30 68369 Saraswathi 38 P2L2 10 Normal Normal Normal 
31 4014 Saral 41 P3L3 5 I.m. myoma I.m. myoma I.m. myoma 
32 5285 Pappathi 48 P4L4 6 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
33 1003 Krishnaveni 38 P3L3 8 S.m. myoma S.m. myoma S.m. myoma 
34 4140 Umarani 50 P6L6 9 Normal Normal Normal 
35 7863 Thulasimani 49 P5L5 5 S.m. myoma End. Hyperplasia End. Hyperplasia 
36 7677 Karuppathal 47 P4L4 6 S.m. myoma End. Polyp End. Polyp 
37 5664 Kalpana 36 P2L2 4 End. Hyperplasia End. Polyp End. Polyp 
38 10302 Rajeshwari 37 P3L3 8 Normal Normal Normal 
39 8687 Rangammal 46 P4L4 7 I.m. myoma I.m. myoma I.m. myoma 
40 13049 Sakunthala 50 P4L4 24 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
41 11280 Joice 42 P3L3 9 I.m. myoma I.m. myoma I.m. myoma 
42 32031 Mallika 48 P6L6 6 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
43 13054 Sampoornam 40 P3L3 5 S.m. myoma S.m. myoma S.m. myoma 
44 11281 Rajammal 38 P3L3 10 I.m. myoma I.m. myoma I.m. myoma 
45 16670 Devika 29 P2L2 11 Normal Normal Normal 
46 17507 Jyothi 45 P4L4 9 I.m. myoma I.m. myoma I.m. myoma 
47 15661 Valarmathi 40 P3L3 2 S.m. myoma S.m. myoma S.m. myoma 
48 18374 Doulath nisha 37 P2L2 10 Normal Normal Normal 
49 18374 Banumathi 46 P4L4 8 I.m. myoma I.m. myoma I.m. myoma 
50 19030 Kasiyammal 46 P3L3 6 Normal Normal Normal 
51 20882 Vasantha 41 P3L3 5 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
52 18373 Selvi 44 P4L4 5 S.m. myoma S.m. myoma S.m. myoma 
53 23949 Rajamani 36 P2L2 24 Normal Normal Normal 
54 22456 Shanthi 40 P3L3 8 S.m. myoma I.m. myoma I.m. myoma 
55 26415 Mahalakshmi 48 P5L5 4 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
56 27995 Baby 47 P4L4 7 End. Polyp End. Polyp End. Polyp 
57 23998 Usha devi 46 P3L3 8 Normal Normal Normal 
58 28010 Anitha 37 P2L2 4 S.m. myoma S.m. myoma S.m. myoma 
59 30456 Selvi 32 P3L3 10 Normal Normal Normal 
60 28162 Nagalakshmi 39 P2L2 13 End. Hyperplasia End. Hyperplasia End. Polyp 
61 32112 Kamalam 49 P4L4 6 End. Polyp End. Polyp End. Polyp 
62 31259 Mahalakshmi 43 P3L3 10 S.m. myoma S.m. myoma S.m. myoma 
63 32829 Aysha 47 P3L3 24 Normal Normal Normal 
64 34387 Vahitha banu 51 P3L3 4 End. Hyperplasia I.m. myoma I.m. myoma 
65 33510 Girija 45 P3L3 8 End. Hyperplasia S.m. myoma S.m. myoma 
66 41003 Rajeshwari 47 P4L4 14 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
67 39218 Jothimani 28 P3L3 24 Normal Normal Normal 
68 38373 Kasthuri 36 P2L2 3 S.m. myoma S.m. myoma S.m. myoma 
69 37544 Priya 39 P3L3 11 Normal Normal Normal 
70 949 Subbulakshmi 37 P2L2 5 I.m. myoma S.m. myoma S.m. myoma 
71 5609 Amudha 46 P4L4 9 Normal Normal Normal 
72 7900 Chandramani 48 P6L6 6 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
73 8687 Rangammal 44 P3L3 7 I.m. myoma S.m. myoma End. Hyperplasia 
74 79321 Reshma 34 P2L2 10 Normal Normal Normal 
75 1193 Saraswathi 46 P4L4 4 S.m. myoma S.m. myoma S.m. myoma 
76 1963 Chandra 49 P4L4 6 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
77 1193 Suganthi 47 P3L3 5 End. Hyperplasia End. Hyperplasia I.m. myoma 
78 9668 Thulasimani 38 P2L2 8 End. Polyp End. Polyp End. Polyp 
79 9732 Kaliyammal 48 P5L5 10 Normal Normal Normal 
80 10567 Mahadevi 50 P6L6 3 End. Hyperplasia End. Hyperplasia Enometrial Ca 
81 49589 Vanaja 39 P3L3 5 S.m. myoma S.m. myoma S.m. myoma 
82 7926 Rajeshwari 33 P1L1 9 Normal Normal Normal 
83 15062 Vasanthi 36 P2L2 11 Normal Normal Normal 
84 13371 Chitra 41 P3L3 3 End. Polyp End. Polyp End. Polyp 
85 15903 Parimala 40 P3L3 7 S.m. myoma S.m. myoma S.m. myoma 
86 15046 Yagoba 49 P5L5 6 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
87 14125 Tamil selvi 47 P4L4 9 Normal Normal Normal 
88 17560 Mangayar thilagam 46 P3L3 5 S.m. myoma S.m. myoma S.m. myoma 
89 18726 Sankarammal 43 P3L3 8 I.m. myoma I.m. myoma S.m. myoma 
90 20135 Mala 29 P2L2 10 Normal Normal Normal 
91 18746 Angammal 38 P2L2 2 End. Polyp End. Polyp End. Polyp 
92 25184 Sundari 42 P3L3 12 Normal Normal Normal 
93 28347 Suguna 37 P2L2 24 Normal Normal Normal 
94 30654 Danalakshmi 44 P4L4 5 End. Hyperplasia End. Hyperplasia End. Hyperplasia 
95 25832 Malarvizhi 40 P3L3 4 I.m. myoma S.m. myoma End. Hyperplasia 
96 55871 Shanthi 51 P5L5 8 Normal Normal Normal 
97 55359 Periyammal 48 P4L4 6 I.m. myoma S.m. myoma S.m. myoma 
98 58371 Ayisha 38 P3L3 8 Normal Normal Normal 
99 58422 Ramathal 46 P4L4 7 S.m. myoma S.m. myoma S.m. myoma 
100 5943 Sabitha 39 P3L3 36 Normal Normal Normal 
  
 
 
 
 
ANNEXURE III 
 
xg;g[jy; gotk; 
 
bgah;   : 
taJ   : 
Kfthp  : 
 
 muR nfhit kUj;Jtf; fy;Y}hpapy; kfg;ngW kw;Wk; bgz;fs; 
kUj;jt Jiwapy; gl;;l nkw;gog;g[ gapYk; khztp it.b$.gpUe;jh mth;fs; 
nkw;bfhs;Sk; “khWgl;l fUg;ig cjpug;nghf;fpd; fhuzpfisf; 
fz;lwptjpy; gpwg;g[Wg;gpd; tHpahf !;nfd; kw;Wk; fh;g;gigapy; ePh; brYj;jp 
!;nfd; bra;tjpd; g';fpidf;  fz;lwpe;J mtw;iw jpRg; ghpnrhjid 
Kot[fSld; xg;gpLjy;” gw;wpa Ma;tpy; bra;Kiw kw;Wk; midj;J 
tpsf;f';fisa[k; nfl;Lf; bfhz;L vdJ re;njf';fis bjspt[g;gLj;jpf; 
bfhz;nld; vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
 ehd; ,e;j Ma;tpy; KG rk;kjj;JlDk;/ Ra rpe;jida[lDk; fye;J 
bfhs;s rk;kjpf;fpnwd;. 
,e;j ma;tpy; vd;idg; gw;wpa midj;J tptu';fs; 
ghJfhf;fg;gLtJld; ,jd; Kot[fs; Ma;tpjHpy; btspaplg;gLtjpy; 
Ml;nrgid ,y;iy vd;gij bjhptpj;Jf; bfhs;fpnwd;. ve;j neuj;jpYk; 
,e;j Ma;tpy; ,Ue;J ehd; tpyfpf; bfhs;s vdf;F chpik cz;L 
vd;gija[k; mwpntd;. 
 
,lk; : 
njjp :        ifbahg;gk; / nuif 
WRITTEN INFORMED CONSENT 
 
 I,                    age          resident  of            have been explained 
the details about the above mentioned study and  hereby give my 
consent for participating in the study titled “Role of Transvaginal 
Sonography and Saline Contrast Sonography in the Evaluation of 
AUB and  its Correlation with Histopathology”. I am told that if 
accepted, this study may be published in scientific journals. I give my 
approval for the same provided no personal details of identifying features 
are mentioned. 
 
 
 
Place:      signature: 
Date:      Name: 
 
 
 
 
 
 
